PHRI Senior Scientist, Shamir Mehta, received the 2022 Canadian Cardiovascular Society (CCS) Research Achievement Award tonight at the Canadian Cardiovascular Congress in Ottawa.

This most prestigious of the CCS awards, created in 1982 in recognition of research excellence, is given to an established investigator working on an aspect of cardiovascular research in Canada.

PHRI Senior Scientist Shamir Mehta receives award from CCS president, Marc Ruel, at the Canadian Cardiovascular Congress 2022 in Ottawa.

Mehta, who heads the Acute Coronary Syndromes and Interventional Cardiology PHRI, led the landmark COMPLETE trial (NEJM 2019). That trial informed the 2021 guidelines for coronary artery revascularization published by the ACC/AHA/SCAI (with highest levels of recommendation and evidence), and has continued to yield insights – as recently as ACC 2022 where Mehta presented a COMPLETE analysis of angina-related quality of life (JAMA Cardiology, 2022).

Last year, Mehta received an endowed chair for interventional cardiology – the Douglas Holder/PHRI Chair – worth $2 million to support his ongoing research that’s breaking new ground in his field.

Previous recipients of the annual CCS Research Achievement Award have included PHRI Senior Scientist Stuart Connolly (2014); and PHRI Executive Director Salim Yusuf (1999).

Back To Top